Skip to main navigation Skip to search Skip to main content

Use of High-dose Intravenous Immunoglobulin as Initial Therapy for Heparin-induced Thrombocytopenia in Patients With High Bleeding Risk

  • Alison V. Grazioli*
  • , Michael E. Plazak
  • , Cynthia S. Shen
  • , Thomas M. Scalea
  • , Rishi Kundi
  • , Ramon A. Riojas
  • , Leonid A. Belyayev
  • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)660-664
Number of pages5
JournalJournal of Cardiothoracic and Vascular Anesthesia
Volume40
Issue number2
DOIs
StatePublished - Feb 2026

Keywords

  • bleeding
  • direct thrombin inhibitors
  • heparin induced thrombocytopenia
  • intravenous immunoglobulin

Fingerprint

Dive into the research topics of 'Use of High-dose Intravenous Immunoglobulin as Initial Therapy for Heparin-induced Thrombocytopenia in Patients With High Bleeding Risk'. Together they form a unique fingerprint.

Cite this